Trial Outcomes & Findings for Diabetic Foot Infection Antibiotic Study (NCT NCT01539811)
NCT ID: NCT01539811
Last Updated: 2022-07-21
Results Overview
Wound healing at 3 months (75% epithelialization) from the time of the final definitive operation.
Recruitment status
TERMINATED
Study phase
NA
Target enrollment
2 participants
Primary outcome timeframe
3 months
Results posted on
2022-07-21
Participant Flow
Participant milestones
| Measure |
Short Course Antibiotics
Surgical intervention followed by short course of antibiotics (\<2 weeks)
Surgical incision and drainage of diabetic foot infection: Incision and drainage of diabetic foot infection with or without amputation of toes or the forefoot, depending on the condition of the foot
Short course antibiotics: Short course (\<2 weeks) of antibiotics will be prescribed
|
Long Course Antibiotics
Surgical intervention followed by a long course of antibiotics (\>2 weeks)
Surgical incision and drainage of diabetic foot infection: Incision and drainage of diabetic foot infection with or without amputation of toes or the forefoot, depending on the condition of the foot
Long course antibiotics: Long course (\>2 weeks) of antibiotics will be prescribed
|
|---|---|---|
|
Overall Study
STARTED
|
0
|
0
|
|
Overall Study
COMPLETED
|
0
|
0
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Diabetic Foot Infection Antibiotic Study
Baseline characteristics by cohort
Baseline data not reported
PRIMARY outcome
Timeframe: 3 monthsPopulation: study closed with only 2 patient enrolled, who were both deemed ineligible prior to the outcome measure window. No patients reached the 3 month time period for the outcome measure.
Wound healing at 3 months (75% epithelialization) from the time of the final definitive operation.
Outcome measures
Outcome data not reported
Adverse Events
Short Course Antibiotics
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Long Course Antibiotics
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place